Ignite Creation Date:
2025-12-26 @ 11:12 PM
Ignite Modification Date:
2025-12-26 @ 11:12 PM
Study NCT ID:
NCT00179712
Status:
COMPLETED
Last Update Posted:
2016-12-01
First Post:
2005-09-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Sponsor:
Celgene Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-11
Completion Date Type:
None
First Submit Date:
2005-09-10
First Submit QC Date:
None
Study First Post Date:
2005-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-30
Last Update Post Date:
2016-12-01
Last Update Post Date Type:
ESTIMATED